Development and validation of a prognostic index for survival in non-small cell lung cancer: Results from a Tunisian cohort study

PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients

In cancer treatment, programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors are

DIAGNOSTIC ACCURACY OF SERUM SQUAMOUS CELL CARCINOMA ANTIGEN AND CARCINOEMBRYONIC ANTIGEN IN DETECTING NON-SMALL CELL LUNG CANCER: A CROSS-SECTIONAL STUDY FROM SOKOTO, NORTHWESTERN NIGERIA

Background: Lung cancer is one of the leading causes of cancer incidence and cancer-related deaths g

Development and validation of a predictive score of venous thromboembolism in patients with lung cancer: Tunisian Survey

Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data

ABSTRACT Background Stillbirth remai

Histological subtype and tumour differentiation as predictors of survival among patients with non-small cell lung cancer in specialised hospitals in Ethiopia

Introduction: non-small cell lung cancer accounts for most lung cancer-related deaths worldwide. Alt

Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans

Abstract Because existing risk prediction models for lung cancer were developed in